Development of a teicoplanin loading regimen that rapidly achieves target serum concentrations in critically ill patients with severe infections
Tóm tắt
Từ khóa
Tài liệu tham khảo
Assandri, 1987, Binding of teicoplanin to human serum albumin, Eur J Clin Pharmacol, 33, 191, 10.1007/BF00544566
Pea, 2003, Teicoplanin therapeutic drug monitoring in critically ill patients: a retrospective study emphasizing the importance of a loading dose, J Antimicrob Chemother, 51, 971, 10.1093/jac/dkg147
MacGowan, 1998, Pharmacodynamics, pharmacokinetics, and therapeutic drug monitoring of glycopeptides, Ther Drug Monit, 20, 473, 10.1097/00007691-199810000-00005
Matsumoto, 2013, Development of initial loading procedure for teicoplanin in critically ill patients with severe infections, Biol Pharm Bull, 36, 1024, 10.1248/bpb.b12-00911
Ueda, 2014, High-dose regimen to achieve novel target trough concentration in teicoplanin, J Infect Chemother, 20, 43, 10.1016/j.jiac.2013.08.006
Bonati, 1998, Pharmacokinetics of a single intravenous dose of teicoplanin in subjects with various degrees of renal impairment, J Antimicrob Chemother, 21, 29, 10.1093/jac/21.suppl_A.29
Senior, 2009, Monitoring for hepatotoxicity: what is the predictive value of liver “function” tests?, Clin Pharmacol, 85, 331
Rybak, 2009, Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists, Am J Health Syst Pharm, 66, 82, 10.2146/ajhp080434
Youden, 1950, Index for rating diagnostic tests, Cancer, 3, 32, 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3
Vincent, 1996, The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure, Intensive Care Med, 22, 707, 10.1007/BF01709751
Bellomo, 2004, Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group, Crit Care – London Engl, 8, R204, 10.1186/cc2872
Gando, 2006, A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria, Crit Care Med, 34, 625, 10.1097/01.CCM.0000202209.42491.38
Mimoz, 2006, Steady-state trough serum and epithelial lining fluid concentrations of teicoplanin 12 mg/kg per day in patients with ventilator-associated pneumonia, Intensive Care Med, 32, 775, 10.1007/s00134-006-0136-3
Yano, 2007, Variability in teicoplanin protein binding and its prediction using serum albumin concentrations, Ther Drug Monit, 29, 399, 10.1097/FTD.0b013e3180690755
Lamont, 2009, Development of teicoplanin dosage guidelines for patients treated within an outpatient parenteral antibiotic therapy (OPAT) programme, J Antimicrob Chemother, 64, 181, 10.1093/jac/dkp147
Shiraishi, 2012, Elimination of teicoplanin by adsorption to the filter membrane during haemodiafiltration: screening experiments for linezolid, teicoplanin and vancomycin followed by in vitro haemodiafiltration models for teicoplanin, Anaesth Intensive Care, 40, 442, 10.1177/0310057X1204000309
Hayakawa, 2001, Appropriateness of MRSA infection remedy based on therapeutic drug monitoring of teicoplanin, TDM Kenkyu, 8, 179
Wilson, 1998, Comparative safety of teicoplanin and vancomycin, Int J Antimicrob Agents, 10, 143, 10.1016/S0924-8579(98)00025-9